Renting cancer trial participation study
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial studies how people with kidney cancer decide to join clinical studies. It looks at trends in participation to help make future studies better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with kidney cancer (renal cell carcinoma).
- You are at least 18 years old.
- You plan to enroll in a clinical study.
- You can understand and sign a consent form.
- You can do regular electronic reporting.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study enrolls people newly diagnosed with kidney cancer (including when it has spread) to help build research resources for future kidney cancer care. If you qualify, your information may be used to better understand outcomes and improve treatments.
This trial tests a combination of three medicines—pembrolizumab (a drug that helps your immune system fight cancer), belzutifan, and lenvatinib (drugs that slow tumor growth)—in patients with early-stage kidney cancer who are candidates for surgery. The goal is to see if this combination can improve outcomes before or alongside surgery.
This trial tests whether CyberKnife (high-precision radiation) can treat early-stage kidney cancer. It may help people avoid or delay more invasive treatments by targeting the tumor while protecting nearby organs.
This trial tests whether personalized monitoring of cancer DNA in your blood (MRD) can guide treatment decisions after kidney cancer surgery. If MRD is detected, you may receive extra immunotherapy to reduce the risk of cancer returning.
This study looks at how people with bladder cancer decide to join clinical trials. You may help researchers understand what matters most to patients like you.
This study follows people with kidney cancer who are scheduled for surgery to remove their tumor. It aims to learn more about the disease and how it behaves over time.
Hear when a new Renal Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.